Searchable abstracts of presentations at key conferences on calcified tissues

ba0005p232 | Energy metabolism and bone, fat and bone | ECTS2016

Significant correlation between vasculopathy and bone mineral density in T2DM: new light shed on diabetic osteoporosis

Zhong Ni , Xu Mingxin , Su Junlei , Zhang Zhiyin , Cui Ran , Ma Yuelong , Sheng Chunjun , Zhang Ge , Sheng Hui , Qu Shen

Purpose: Osteoporosis (OP) aggravates with vasculature degeneration and improvement of vasculature could prevent OP. We, thus, hypothesize that vascular structure and function play an important role in the development of OP. Type 2 diabetes mellitus (T2DM) patients are vulnerable to vasculopathy, so T2DM were involved in this project to study the correlation between vasculopathy and bone mineral density (BMD).Methods: A total of 427 (180 in OP group; 247...

ba0005p230 | Energy metabolism and bone, fat and bone | ECTS2016

The interrelationship of 25-hydroxyvitamin D and osteocalcin on glycolipid metabolism: a cross-sectional study in type 2 diabetics

Su Junlei , Xu Mingxin , Hao Jie , Zhang Zhiyin , Zhong Ni , Cui Ran , Xu Bei , Li Feng , Feng Tienan , Zhang Ge , Sheng Hui , Qu Shen

Context: As bone metabolic markers, recent studies indicated vitamin D and osteocalcin (OC) were also involved in energy metabolism. While the exact relationship between vitamin D and OC in regulating energy metabolism is unclear. One of the possibilities is that: low vitamin D could lead to secondary hyperparathyroidism and following high bone turnover, which would enhance the quantity of bioactive OC.Objective: Our aim was to study whether OC mediated ...

ba0003pp70 | Bone development/growth and fracture repair | ECTS2014

The roles of CDC42 in bone development

Wang Jirong , Gong Ying , Xu Chengyun

Members of the Rho family including small GTPase Cdc42 have been shown to play multiple roles in cell regulation, including regulation of cytoskeletal organization, cell migration, proliferation, and apoptosis. However, their tissue-specific roles in vivo, especially in limb bud mesenchyme, remain largely unknown. Herein, we report that conditional deletion of Cdc42 in AER dose not change the limb development, however, knockout of Cdc42 in mesenchymal stem cells of li...

ba0001pp160 | Cancer and bone: basic, translational and clinical | ECTS2013

Glucose ceramide synthase inhibitors prevent osteoclast activation and limit myeloma-induced osteolytic lesions

Ersek Adel , Xu Ke , Karadimitris Anastasios , Horwood Nicole J

Glycosphingolipids (GSL) are essential structural components of mammalian cell membranes and lipid rafts that exert pleiotropic effects on cell survival, proliferation, and differentiation. Cancer associated GSL have been shown to promote tumor growth, angiogenesis, and metastasis; however their role in osteoclast (OC) activation and the development of osteolytic bone diseases such as multiple myeloma are not known. We investigated the hypothesis that GSL contribute to OC acti...

ba0001pp213 | Cell biology: osteoclasts and bone resorption | ECTS2013

Anti-dementia acetylcholine esterase inhibitor inhibits osteoclastogenesis

Inderjeeth Charles , Xu Jiake , Bay Sie Lim , Teguh Dian

Background: Alzheimer’s dementia (AD) and osteoporosis (OP) are common and parallel ageing and frequently coexist in an ageing population. Low BMD appears related to increased risk of AD. Various clinical conditions have been shown to alter acetylcholine (Ach) signalling and affect bone. Ach receptor (AchR) subunits and Ach esterase (AchE) are expressed in bone. Presynaptic Botox inhibit Ach release and impair bone healing and decrease bone mineral content. Poliomyelitis ...

ba0001pp441 | Osteoporosis: treatment | ECTS2013

Reducing the risk of hypocalcaemia with parenteral antiresorptive therapies: an audit

Xu Wei , Baker Kenneth , Reavley Rachel , Oates Emily , Aspray Terry

Introduction: Intravenous bisphosphonates (IB) and subcutaneous denosumab (SD) are potent antiresorptive agents widely used in the treatment of osteoporosis, Paget’s disease and metastatic malignancy. Several case reports have identified the risk of life-threatening hypocalcaemia with these treatments, particularly in the context of vitamin D deficiency and further highlighted by recent UKMHRA advice.Design: To optimise vitamin D status and decrease...

ba0004op3 | (1) | ICCBH2015

Increase of preosteoclasts and secretion of PDGF-BB by inhibition of cathepsin K activity increases mouse bone mass during development

Crane Janet , Ye Zixing , Xie Hui , Xia Zhuying , Cao Xu

Objective: Accretion of bone mass in childhood is dependent on both bone modeling and remodeling. We recently found that preosteoclasts secrete platelet derived growth factor type BB (PDGF-BB) to promote angiogenesis coupling with osteogenesis during both modeling and remodeling. As secretion of PDGF-BB by preosteoclasts can be enhanced through inhibition of cathepsin K activity to increase bone mass in adults, we explored if increase of secretion of PDGF-BB by preosteoclasts ...

ba0005p161 | Cell biology: osteoblasts and bone formation | ECTS2016

Vaspin regulates the osteogenic differentiation of MC3T3-E1 through the PI3K-Akt/miR-34c loop

Liu Yuan , Xu Feng , Pei Hong-Xia , Yuan Ling-Qing

Vaspin (visceral adipose tissue-derived serine protease inhibitor) is a newly discovered adipokine that widely participates in diabetes mellitus, polycystic ovarian syndrome and other disorders of metabolism. However, the effect of vaspin on the regulation of osteogenesis and the mechanism responsible are still unclear. Here, we found that vaspin could attenuate the ALP activities, osteocalcin secretion and Runx2 expression in the preosteoblast cell line MC3T3-E1 in a dose-dep...

ba0006oc18 | (1) | ICCBH2017

Stimulation of angiogenesis and osteogenesis by enhanced preosteoclast platelet derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice

Yang Ping , Wang Yan , Xia Zhuying , Cao Xu , Crane Janet

Survival of chronic diseases in childhood is often achieved utilizing glucocorticoids. However, the survival comes at a cost to the growing skeleton, resulting in impairment in the acquisition of peak bone mass and is the major etiology of secondary osteoporosis in children. We recently found that preosteoclasts secrete platelet derived growth factor type BB (PDGF-BB) to promote angiogenesis and osteogenesis during both modeling and remodeling. As glucocorticoid therapy affect...